Table 2.
Total | BMD | IMD | |||||||
n | % | n | % | n | % | ||||
FVC (%) | 60 | 75.9 | 48.5 +/–20.9 | 31 | 88.6 | 59.2 +/–14.8 | 29 | 65.9 | 36.4 +/–17.3 |
(50.8, 5.9–80.4) | (59.9, 14.0–80.4) | (37.0. 5.9–63.0) | |||||||
no FVC data | 19 | 24.1 | 4 | 11.3 | 15 | 34.1 | |||
ambulation | |||||||||
ambulant | 17 | 21.5 | 17 | 48.6 | 0 | 0.0 | |||
non-ambulant | 62 | 78.5 | 18 | 51.4 | 44 | 100.0 | |||
age at loss of ambulation (y.o.) | 63 | 79.7 | 18.9 +/–11.2 | 18 | 51.4 | 29.4 +/–5.6 | 44 | 100.0 | 14.0 +/–1.0 |
(14, 13–65) | (20, 17–65) | (14, 13–16) | |||||||
Steroid | |||||||||
never | 58 | 73.4 | 28 | 80.0 | 30 | 68.2 | |||
current | 11 | 13.9 | 4 | 11.4 | 7 | 15.9 | |||
former | 10 | 12.7 | 3 | 8.6 | 7 | 15.9 | |||
cardiac function | |||||||||
dysfunction | 53 | 67.1 | 19 | 54.3 | 34 | 77.3 | |||
normal | 26 | 32.9 | 16 | 45.7 | 10 | 22.7 | |||
genotyping | |||||||||
in-frame | 28 | 35.4 | 19 | 54.3 | 9 | 20.5 | |||
out-of-frame | 35 | 44.3 | 6 | 17.1 | 29 | 65.9 | |||
Small mutation | 16 | 20.3 | 10 | 28.6 | 6 | 13.6 | |||
IHC | |||||||||
faint and patchy | 11 | 13.9 | 5 | 14.3 | 5 | 11.4 | |||
negative | 10 | 12.7 | 4 | 11.4 | 7 | 15.9 | |||
no data | 58 | 73.4 | 26 | 74.3 | 32 | 72.7 |